Literature DB >> 20673018

Current status of plant-made vaccines for veterinary purposes.

Huai-Yian Ling1, Assunta Pelosi, Amanda M Walmsley.   

Abstract

Interest is growing for the use of plant-made vaccines for veterinary purposes since the regulatory landscape still enables delivery of either crude extracts or minimally processed plant materials to animals for medicinal purposes. In this article, we highlight the current research directions taken with four diseases considered as important constraints to international trade in animals: avian influenza, Newcastle disease, foot-and-mouth disease and diarrheal disease caused by enterotoxigenic Escherichia coli. We also discuss appropriate plant production platforms with regards to plant species and transformation methodologies, possible areas of development, and the remaining challenges for plant-made vaccines for veterinary purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673018     DOI: 10.1586/erv.10.87

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  7 in total

1.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

Review 2.  Evolution of plant-made pharmaceuticals.

Authors:  David R Thomas; Claire A Penney; Amrita Majumder; Amanda M Walmsley
Journal:  Int J Mol Sci       Date:  2011-05-17       Impact factor: 5.923

3.  An interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccines.

Authors:  Huai-Yian Ling; Aaron M Edwards; Michael P Gantier; Kathleen D Deboer; Alan D Neale; John D Hamill; Amanda M Walmsley
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 4.  Plant-made vaccines in support of the Millennium Development Goals.

Authors:  Claire A Penney; David R Thomas; Sadia S Deen; Amanda M Walmsley
Journal:  Plant Cell Rep       Date:  2011-01-18       Impact factor: 4.570

5.  Transient Bluetongue virus serotype 8 capsid protein expression in Nicotiana benthamiana.

Authors:  Albertha R van Zyl; Ann E Meyers; Edward P Rybicki
Journal:  Biotechnol Rep (Amst)       Date:  2015-12-07

Review 6.  Plant Platforms for Efficient Heterologous Protein Production.

Authors:  Siddhesh B Ghag; Vinayak S Adki; Thumballi R Ganapathi; Vishwas A Bapat
Journal:  Biotechnol Bioprocess Eng       Date:  2021-08-07       Impact factor: 2.836

Review 7.  Plant-based oral vaccines against zoonotic and non-zoonotic diseases.

Authors:  Naila Shahid; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2016-08-23       Impact factor: 9.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.